Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

19/10/2026

Carvykti® (ciltacabtagene autoleucel). Disponibile il report tecnico-scientifico

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

06/10/2026

Newsletter Disuguaglianze di salute n.57

Agendas and minutes

19/10/2026

Agenda - EMA Methodology Working Party (MWP) interested parties meeting 2026

Consumer Updates RSS Feed

05/10/2026

Advisory Committees Give FDA Critical Advice and the Public a Voice

Regulatory and procedural guidelines (human and veterinary)

19/10/2026

Draft Data Quality Framework (DQF) for EU medicines regulation: application to collection, management and submission of Adverse Drug Reaction reports

Scientific guidelines (human and veterinary)

19/10/2026

Reflection paper on methodological aspects in confirmatory platform trials

Paediatric investigation plans

14/10/2026

Opinion/decision on a Paediatric investigation plan (PIP): Opdualag, nivolumab,relatlimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0169/2024

Orphan designations

07/10/2026

Orphan designation: somapacitan Treatment of growth hormone deficiency, 24/08/2018 Withdrawn

New medicines and opinions: human

16/10/2026

Human medicines European public assessment report (EPAR): Fovlussea, ranibizumab, Ophthalmologicals, Status: Opinion

MedWatch Safety Alerts RSS Feed

19/10/2026

Diagnostic Ultrasound System Correction: Philips Ultrasound Issues Updated Use Instructions for Lumify Diagnostic Ultrasound System

What's New: Drugs RSS Feed

19/10/2026

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis